Article information
Full text is only aviable in PDF
Bibliografía
[1.]
J.T. Lie.
The classification and diagnosis of vasculitis in large and mediu-sized blood vessels.
Pathol Annu, 22 (1987), pp. 125-162
[2.]
J.T. Lie.
Systemic and isolated vasculitis: a rational approach to classification and pathologic diagnosis.
Pathol Annu, 24 (1989), pp. 25-114
[3.]
J. Churg, A. Churg.
Idiopathic and secondary vasculitis: a review.
Mod Pathol, 2 (1989), pp. 144-160
[4.]
J.T. Lie.
Vasculitis, 1815 to 1991: classification and diagnostic specificity (Dunlop-Dottridge lecture).
J Rheumatol, 19 (1991), pp. 83-89
[5.]
C.J. Jennette, D.M. Milling, R.J. Falk.
Vasculitis affecting the skin.
Arh Dermatol, 130 (1994), pp. 899-906
[6.]
R.P. McCombs.
Diseases due to immunologic reactions in the lung.
N Engl J Med, 286 (1972), pp. 1.186-1.194
[7.]
R.Y. Leavitt, A.S. Fauci.
Pulmonary vasculitis.
Am Rev Respir Dis, 134 (1986), pp. 149-166
[8.]
R.P. McCombs.
Systemic allergic vasculitis: clinical and pathological relationships.
JAMA, 194 (1965), pp. 1.059-1.064
[9.]
Rosenow III, J.T. Lie.
The pulmonary vasculitidis.
Update: Pulmonary diseases and disorders, pp. 465-474
[10.]
P. Gaulard, T. Henni, J.P. Marolleau, et al.
Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis. Evidence of a monoclonal T-cell lymphoproliferative disorder.
Cancer, 62 (1988), pp. 705-710
[11.]
E.S. Jaffe, E.H. Lipford, J.B. Margolick.
Lymphomatoid granulomatosis and angiocentric lymphoma: a spectrum of postthymic T-cell proliferations.
Semin Respir Med, 10 (1989), pp. 167-172
[12.]
J.C. Jennette, L.A. Charles, R.J. Falk.
The neutrophil and its role in systemic vasculitis.
The biologic basis of systemic vasculitis, pp. 65-92
[13.]
A.H.M. Heurkens, P.S. Hiemstra, G.J.M. Lafeber, M.R. Daha, F.C. Breedveld.
Anti-endothelial cell antibodies, in patients with rheumatoid vasculitis.
Arthritis Rheum, 32 (1989), pp. 1.191-1.192
[14.]
C.O.S. Savage, S.P. Cooke.
The role of endothelium in systemic vasculitis.
J Autoimmunity, 6 (1993), pp. 237-249
[15.]
A.S. Fauci, B.F. Haynes, P. Katz.
The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations.
Ann Intern Med, 89 (1978), pp. 660-676
[16.]
R.T. McCluskey, R. Fienberg.
Vasculitis in primary vasculitides. granulomatoses and connective tissue diseases.
Hum Pathol, 14 (1983), pp. 305-315
[17.]
M. Schatz, R. Patterson, J. Fink.
Immunologic lung disease.
N Engl J Med, 300 (1979), pp. 1.310-1.320
[20.]
M.L. Applebaum, G.W. Hunninghake.
The lung in the systemic vasculitides.
Immunology and immunologic diseases of the lung. Cambridge, pp. 411-427
[21.]
M. Vilardell, J.A. Bosch.
Las vasculitis.
Temas actuales de Reumatología, pp. 283-322
[22.]
C.H. Hu, S. O’Loughlin, R.K. Winkelman.
Cutaneous manifestations of Wegener's granulomatosis.
Arch Dermatol, 113 (1977), pp. 175-182
[23.]
D.M. Shasby, M.I. Schwarz, J.Z. Forstot, A.N. Theofilopoulos, S.S. Kassan.
Pulmonary immune complex deposition in Wegener's granulomatosis.
Chest, 81 (1982), pp. 338-340
[24.]
R.J. Falk, J.C. Jennette.
Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculits and idiopathic necrotizing and crescentic glomerulonephritis.
N Engl J Med, 318 (1988), pp. 1.651-1.657
[25.]
J.C. Jennette, A.S. Wilkman, R.J. Falk.
Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis.
Am J Pathol, 135 (1989), pp. 921-930
[26.]
W.L. Gross, E. Csernok, B.K. Flesch.
«Classic» anti-neutrophil cytoplasmic autoantibodies (cANCA). «Wegener's autoantigen» and their immunopathogenic role in Wegener's granulomatosis.
J Autoimmun, 6 (1993), pp. 171-184
[27.]
P. Lesavre.
Antineutrophil cytoplasmic autoantibodies antingen specifity.
Am J Kidney Dis, 2 (1991), pp. 159-163
[28.]
X. Bosch, J. Font, E. Mirapeix.
Anticuerpos anticitoplasma de neutrófilo.
Med Clin (Barc), 98 (1992), pp. 348-354
[29.]
C.G.M. Kallenberg.
Anti-neutrophil cytoplasmic antibodies (ANCA): current perspectives.
Rheumatol Eur, 23 (1994), pp. 5-6
[30.]
C.G.M. Kallenberg, A.H.L. Mulder, J.W.C. Tervaert.
Antineutrophil cytoplasmic antibodies: a still-growing class of auto-antibodies in inflammatory disorders.
Am J Med, 93 (1992), pp. 675-682
[31.]
J.C. Jennette, R.J. Falk.
The coming of age of serologic testing for anti-neutrophil cytoplasmic auto-antibodies.
Mayo Clin Proc, 69 (1994), pp. 908-910
[32.]
R.A. De Remee, H.A. Homburger, U. Specks.
Lesions of the respiratory tract associated with the finding of antineutrophil cytoplasmic autoantibodies with a perinuclear staining pattern.
Mayo Clin Proc, 69 (1994), pp. 819-824
[33.]
U. Specks, C.L. Wheatley, T.J. McDonald, M.S. Rohrbach, R.A. De Remee.
Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener's granulomatosis.
Mayo Clin Proc, 64 (1989), pp. 28-36
[34.]
G.S. Hoffman, J.M.G. Sechler, J.I. Gallin, et al.
Bronchoalveolar lavage analysis in Wegener's Granulomatosis. A method to study disease pathogenesis.
Am Rev Respir Dis, 143 (1991), pp. 401-407
[35.]
R.J. Baltaro, G.S. Hoffman, J.M.G. Sechler, et al.
Immunoglobulin G antineutrophil cytoplasmic antibodies are produced in the respiratory tract of patients with Wegener's Granulomatosis.
Am Rev Respir Dis, 143 (1991), pp. 275-278
[36.]
E.C. Hagen, B.E.P.B. Ballieux, E.S.L.A. Van, M.R. Daha, F.J. Van der Wonde.
Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences.
Blood, 81 (1993), pp. 1.996-2.002
[37.]
D.J. Beer.
ANCAs aweigh.
Am Rev Respir Dis, 146 (1992), pp. 1.128-1.130
[39.]
W.L. Gross, W.H. Schmitt, E. Csernok.
ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.
Clin Exp Immunol, 91 (1993), pp. 1-12
[40.]
J.C. Jennette, B.H. Ewert, R.J. Falk.
Do Antineutrophil cytoplasmic autoantibodies cause Wegener's granulomatosis and other forms of necrotizing vasculitis.
Rheum Dis Clin North Am, 19 (1993), pp. 1-14
[41.]
E. Brouwer, M.G. Huitema, P.A. Flok, et al.
Antimyeloperoxidaseassociated proliferative glomerulonephritis: an animal model.
J Exp Med, 177 (1993), pp. 905-914
[42.]
R. Cervera, J. Montalbán, M.A. Khamashta.
Anticuerpos anticélula endotelial.
Med Clin (Barc), 95 (1990), pp. 712-715
[43.]
L. Brasile, J.M. Kremer, J.L. Clarke, J. Cerilli.
Identification of an autoantibody to vascular endothelial cell-specific antigens in patients with systemic vasculitis.
Am J Med, 87 (1989), pp. 74-80
[44.]
N. Del Papa, P.L. Meroni, W. Barcellini, et al.
Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells.
Clin Immunol Immunopathol, 63 (1992), pp. 267-274
[45.]
C. Edelsten, D. D’Cruz, G.R.V. Hughes, E.M. Graham.
Antiendothelial cell antibodies in retinal vasculitis.
Curr Eye Res, 11 (1992), pp. 203-208
[46.]
P.L. Meroni, N. Del Papa, D. Gambini, W. Barcellini, G.A. McCarty, K.A. Lister.
Endothelium as a target for the immune injury in systemic vasculitis.
Contrib Nephrol, 99 (1992), pp. 1-6
[47.]
H. Direskeneli, D. D’Cruz, M.A. Khamashta, G.R.V. Hughes.
Autoantibodies against endothelial cells, extracellular matrix, and human collagen type IV in patients with systemic vasculitis.
Clin Immunol Immunopathol, 70 (1994), pp. 206-210
[48.]
M. Shingu, E.R. Hurd.
Sera from patients with systemic lupus erythematosus reactive with human endothelial cells.
J Rheumatol, 8 (1981), pp. 581-586
[49.]
D.B. Cines, A.P. Lyss, M. Reeber, M. Bina, R.J. Dehoratus.
Presence of complement fixing antiendothelial cell antibodies in systemic lupus erythematosus.
J Clin Invest, 73 (1984), pp. 611-625
[50.]
J.M. Van der Zee, C.E.H. Siegert, T.A. De Vreede, M.R. Daha, F.C. Breedveld.
Characterization of antiendothelial cell antibodies in systemic lupus erythematosus (SLE).
Clin Exp Immunol, 84 (1991), pp. 238-244
[51.]
R. Cervera, M.A. Khamashta, J. Font, et al.
Anticuerpos anticélula endotelial en el lupus eritematoso sistémico: asociación con lesiones vasculares y renales.
Med Clin (Barc), 99 (1992), pp. 605-608
[52.]
A.H.M. Heurkens, P.S. Hiemstra, G.J.M. Lafeber, M.R. Daha, F.C. Breedveld.
Anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by vasculitis.
Clin Exp Immunol, 78 (1989), pp. 7-12
[53.]
J.M. Van der Zee, A.H.M. Heurkens, E.A.M. Van der Voort, M.R. Daha, F.C. Breedveld.
Characterization of antiendothelial antibodies in patients with rheumatoid arthritis complicated by vasculitis.
Clin Exp Rheumatol, 9 (1991), pp. 589-594
[54.]
M. Varagunam, Z. Nwosu, D. Adu, et al.
Little evidence for anti-endothelial cell antibodies in microscopic polyarteritis and Wegener's Granulomatosis.
Nephrol Dial Transplant, 8 (1992), pp. 113-117
[55.]
D. D’Cruz, M.A. Khamashta, G.R.V. Hughes.
Antiendothelial cell antibodies in systemic vasculitis.
Arthritis Rheum, 37 (1994), pp. S268
[56.]
D. D’Cruz.
Anti-endothelial cell antibodies, antiphospholipid antibodies and vascular disease.
Rheumatol Eur, 23 (1994), pp. 6-7
[57.]
D.Y.M. Leung, R.S. Geha, J.W. Newberger, et al.
Two monokines interleukine-1 and tumor necrosis factor render cultured vascular endothelial cells susceptible to lysis by antibodies circulating in Kawasaky syndrome.
J Exp Med, 164 (1986), pp. 1.958-1.972
[58.]
D.Y.M. Leung, T. Collins, L.A. Lapierre, R.S. Geha, J.S. Pober, M. Immunoglobulin.
antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon.
J Clin Invest, 77 (1986), pp. 1.428-1.435
[59.]
G. Ferraro, P.L. Meroni, A. Tincani, et al.
Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis.
Clin Exp Immunol, 79 (1990), pp. 47-53
[60.]
C.O.S. Savage, B.E. Pottinger, G. Gaskin, C.M. Lockwood, C.D. Pusey, J.D. Pearson.
Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of antyendothelial cell antibodies and their relation to antineutrophil cytoplasm antibodies.
Clin Exp Immunol, 85 (1991), pp. 14-19
[61.]
E.J. Tizard, E. Baguley, H.R.V. Hughes, M.J. Dillon.
Anti-endothelial cell antibodies detected by a cellular based ELISA in Kawasaki disease.
Arch Dis Child, 66 (1991), pp. 189-192
[62.]
R.E. Petty, D.W.C. Hunt, A.M. Rosenberg.
Antibodies to type IV collagen in rheumatic diseases.
J Rheumatol, 13 (1986), pp. 246-256
[63.]
L.W. Moreland, R.E. Gay, S. Gay.
Collagen autoantibodies in patients with vasculitis and systemic lupus erythematosus.
Clin Immunol Immunopathol, 60 (1991), pp. 412-418
[64.]
S. Kobayashi, N. Wada, M. Kubo.
Antibodies to native type III collagen in the serum of patients with Kawasaki disease.
Eur J Pediatr, 151 (1992), pp. 183-187
[65.]
G.R.V. Hughes.
El síndrome antifosfolípido: 10 años de estudio.
Lancet (ed. esp.), 24 (1994), pp. 24-27
[66.]
A. Vismara, P.L. Meroni, A. Tincani, et al.
Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus.
Clin Exp Immunol, 74 (1988), pp. 247-253
[67.]
T.A. Springer.
Adhesion receptors of the immune system.
Nature, 346 (1990), pp. 425-434
[68.]
D.E. Stauton, M.L. Dustin, T.A. Springer.
Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1.
Nature, 339 (1989), pp. 61-64
[69.]
J. Fawcett, C.L.L. Holness, L.A. Needham, et al.
Molecular cloning of ICAM-3, a third lingand for LFA-1, constitutively expressed on resting leukocytes.
Nature, 360 (1992), pp. 481-484
[70.]
A. Humbría, R. García de Vicuña, F. Díaz-González, F. SánchezMadrid, A. Laffón.
Integrinas: importancia de la adhesión celular.
Med Clin (Barc), 95 (1990), pp. 630-635
[71.]
R.O. Hynes.
Integrins: versatility, modulation and signaling in cell adhesion.
Cell, 69 (1992), pp. 11-25
[72.]
F. Sánchez-Madrid, A.L. Corbí.
Leukocyte integrins: structure, function and regulation of their activity.
Semin Cell Biol, 3 (1992), pp. 199-210
[73.]
T.K. Kishimoto.
The selectins.
Structure, function and regulation of molecules involved in leukocyte adhesion, pp. 107-133
[74.]
M. Bevilacqua, E. Butcher, B. Furie, et al.
Selectins: a family of adhesión receptors.
Cell, 67 (1991), pp. 233
[75.]
D.M. Lewinsohn, R.F. Bargatze, E.C. Butcher.
Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes and other leukocytes.
J Immunol, 138 (1987), pp. 4.313-4.325
[76.]
M.P. Bevilaqua.
Endothelial-leukocyte adhesión molecules.
Annu Rev Immunol, 11 (1993), pp. 767-804
[77.]
E.C. Butcher.
Leukocyle endothelial cell recognition: three (or more) steps to specificity and diversity.
Cell, 67 (1991), pp. 1.033-1.036
[78.]
R. García de Vicuña, A. Humbría Mendiola, F. Díaz González, A. Laffón.
Adhesión leucocitaria al endotelio vascular: bases para la migración a la membrana sinovial inflamada.
Rev Esp Reumatol, 19 (1992), pp. 338-398
[79.]
B.F. Haynes.
Pathogenic mechanisms of vessel damage.
Inflammation: basic principies and clinical correlates, pp. 921-941
[80.]
C.R. Robertson, R.M. McCallum.
Changing concepts in pathophysiology of the vasculitides.
Curr Opin Rheumatol, 6 (1994), pp. 3-10
[82.]
F. Bussolino, J.M. Wang, P. Defílippi, et al.
Granulocyte and granulocate macrophage colony stimulating factors induce human endothelial cells to migrate and proliferate.
Nature, 337 (1989), pp. 471-473
[83.]
R.A. Swerlick, T.J. Lawley.
Role of microvascular endothelial cell in inflammation.
J Invest Dermatol, 100 (1993), pp. 111-115
[84.]
R.E. Whatley, G.A. Zimmerman, T.M. Mclntyre, R. Taylor, S.M. Prescott.
Production of platelet-activating factor by endothelial cells.
Semin Thromb Flemost, 13 (1987), pp. 445-453
[86.]
A. Lerman, F.L. Hildebran, K.B. Margulies, et al.
Endothelin: a new cardiovascular regulatory peptide.
Mayo Clin Proc, 65 (1990), pp. 1.441-1.455
[87.]
J. Kekow, C.H. Szymkowiak, M. Sticherling, J.M. Schroder, E. Christophers, W.L. Gross.
Pro-and anti-inflammatory cytokines in primary sistemic vasculitis.
Adv Exp Med Biol, 336 (1993), pp. 341-344
[88.]
F.R. Balkwill, F. Burke.
The cytokine network.
Immunol Todas, 10 (1989), pp. 299-304
[91.]
J.M. Álvaro-Gracia.
Citocinas en la membrana sinovial de la artritis reumatoide.
Rev Esp Reumatol, 19 (1992), pp. 378-387
[92.]
N.H. Ruddle.
Tumor necrosis factor and related cytokines.
Immunol Today, 8 (1987), pp. 129-130
[93.]
G. Trinchieri, B. Perussia.
Immune interferon: a pleitotropic lymphokine with múltiple effects.
Immunol Today, 6 (1985), pp. 131-136
[94.]
T. Kishimoto, T. Hirano.
Molecular regulation of B lymphocyte response.
Ann Rev Immunol, 6 (1988), pp. 485-512
[95.]
J. Van Snick.
Interleukin-6. An overview. Ann Rev Immunol, 8 (1990), pp. 253-278
[96.]
J.J. Oppenheim, K. Matsushima, T. Yoshimura, E.J. Leonard, R. Neta.
Relationship between interleukin 1, tumour necrosis factor and a neutrophil attracting peptide (NAP-1).
Agents Actions, 26 (1989), pp. 134-140
[97.]
M. Seitz, B. Dewald, N. Gerber, M. Baggiolini.
Enhanced production of neutrophil-activating factor/interleukin-8 in rheumatoid arthritis.
J Clin Invest, 87 (1991), pp. 463-469
[98.]
A. Rot.
Endothelial cell binding of NAP-1/IL8: role in neutrophil emigration.
Immunol Today, 13 (1992), pp. 291-294
[99.]
G. Trinchieri.
Interleukin-12 and its role in the generation of TH1 cells.
Immunol Today, 14 (1993), pp. 335-338
[100.]
T.R. Mosmann, H. Cherwinski, M.W. Bond, M.A. Giedlin, R.L. Coffman.
Two types of murine helper T cell clone. 1. Deffínition according to profiles of lymphokine activities and secreted proteins.
J Immunol, 136 (1986), pp. 2.348-2.357
[101.]
G. Zurawski, J.E. De Vries.
Interleukine 13, and interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells.
Immunol Today, 15 (1994), pp. 19-26
[102.]
D. Metcalf.
The granulocyte-macrophage colony stimulating factors.
Science, 229 (1985), pp. 16-22
Copyright © 1995. Sociedad Española de Neumología y Cirugía Torácica
